TNDM
Tandem Diabetes Care Inc
NASDAQ: TNDM · HEALTHCARE · MEDICAL DEVICES
$18.16
-2.52% today
Updated 2026-04-29
Market cap
$1.24B
P/E ratio
—
P/S ratio
1.23x
EPS (TTM)
$-3.04
Dividend yield
—
52W range
$10 – $30
Volume
2.3M
Tandem Diabetes Care Inc (TNDM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-20.20%
Operating margin
2.86%
ROE
-97.90%
ROA
-5.28%
Debt/equity
3.64x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-25.51M | — | — | — |
| 2012 | $2.47M | $-33.02M | -54.48% | -1,335.44% | -1,334.11% |
| 2013 | $29.01M | $-63.14M | 21.26% | -170.42% | -217.67% |
| 2014 | $49.72M | $-79.52M | 30.67% | -152.17% | -159.94% |
| 2015 | $72.85M | $-72.42M | 36.49% | -94.72% | -99.41% |
| 2016 | $84.25M | $-83.45M | 28.00% | -92.64% | -99.05% |
| 2017 | $107.60M | $-73.03M | 40.98% | -58.50% | -67.87% |
| 2018 | $183.87M | $-122.61M | 48.85% | -24.27% | -66.68% |
| 2019 | $362.31M | $-24.75M | 53.60% | -4.62% | -6.83% |
| 2020 | $498.83M | $-34.38M | 52.23% | -1.60% | -6.89% |
| 2021 | $702.80M | $15.57M | 53.53% | 3.22% | 2.21% |
| 2022 | $801.22M | $-94.59M | 51.54% | -11.59% | -11.81% |
| 2023 | $747.72M | $-222.61M | 49.17% | -31.19% | -29.77% |
| 2024 | $940.20M | $-96.03M | 52.07% | -10.54% | -10.21% |
| 2025 | $1.01B | $-204.71M | 52.31% | -7.70% | -20.17% |